rdf:type |
|
lifeskim:mentions |
umls-concept:C0014257,
umls-concept:C0016410,
umls-concept:C0019004,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0221099,
umls-concept:C0392747,
umls-concept:C0442739,
umls-concept:C0443172,
umls-concept:C0443252,
umls-concept:C0542341,
umls-concept:C1524112,
umls-concept:C1548568
|
pubmed:issue |
1
|
pubmed:dateCreated |
1998-3-19
|
pubmed:abstractText |
Hyperhomocysteinaemia is frequent in chronic haemodialysis patients. Because of its potential role in athero- and thrombogenesis, the effects of long-term homocysteine-lowering treatment on endothelial function are of interest.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0931-0509
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
106-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9481724-Adult,
pubmed-meshheading:9481724-Aged,
pubmed-meshheading:9481724-Betaine,
pubmed-meshheading:9481724-Endothelium, Vascular,
pubmed-meshheading:9481724-Female,
pubmed-meshheading:9481724-Folic Acid,
pubmed-meshheading:9481724-Homocysteine,
pubmed-meshheading:9481724-Humans,
pubmed-meshheading:9481724-Male,
pubmed-meshheading:9481724-Middle Aged,
pubmed-meshheading:9481724-Renal Dialysis
|
pubmed:year |
1998
|
pubmed:articleTitle |
No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients.
|
pubmed:affiliation |
Department of Internal Medicine, University Hospital, Vrije Universiteit, Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|